Alkermes (ALKS) Cash from Operations (2010 - 2026)

Alkermes' (ALKS) quarterly Cash from Operations came in at 165743000.0 in Q1 2026, down 267.74% year-on-year from 98811000.0 in Q1 2025, and down 197.46% on a QoQ basis from 170069000.0 in Q4 2025.

Alkermes (ALKS) Cash from Operations (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Cash from Operations data on file, last reported at 165743000.0 in Q1 2026.

  • On a quarterly basis, Cash from Operations fell 267.74% year-over-year to 165743000.0 in Q1 2026; TTM through Mar 2026 was 256200000.0, a 50.43% decrease from a year earlier, with the FY2025 full-year figure at 520754000.0, up 18.59% from the prior year.
  • Cash from Operations for Q1 2026 stood at 165743000.0, down from 170069000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for ALKS reached as high as 215710000.0 in Q2 2023 and fell as low as 165743000.0 in Q1 2026.
  • Historically, Cash from Operations has averaged 71560705.88 across 5 years, with a median of 98811000.0 in 2025.
  • Across the five-year window, Cash from Operations jumped 15853.28% in 2023 and sank 267.74% in 2026, its largest moves.
  • Year by year, Cash from Operations stood at 1047000.0 in 2022, then surged by 10142.31% to 107237000.0 in 2023, then soared by 77.55% to 190397000.0 in 2024, then retreated by 10.68% to 170069000.0 in 2025, then plunged by 197.46% to 165743000.0 in 2026.
  • Per Business Quant data, the three most recent Cash from Operations figures were 165743000.0 in Q1 2026, 170069000.0 in Q4 2025, and 101672000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -40.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 401.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 463.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 388.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 145.80 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.00 Mn
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn -165.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -165.74 Mn
Mar 31, 2026 -165.74 Mn
Dec 31, 2025 170.07 Mn
Dec 31, 2025 170.07 Mn
Sep 30, 2025 101.67 Mn
Sep 30, 2025 101.67 Mn
Jun 30, 2025 150.20 Mn
Jun 30, 2025 150.20 Mn
Mar 31, 2025 98.81 Mn
Mar 31, 2025 98.81 Mn
Dec 31, 2024 190.40 Mn
Dec 31, 2024 190.40 Mn
Sep 30, 2024 81.59 Mn
Sep 30, 2024 81.59 Mn
Jun 30, 2024 146.03 Mn
Jun 30, 2024 146.03 Mn
Mar 31, 2024 21.11 Mn
Mar 31, 2024 21.11 Mn
Dec 31, 2023 107.24 Mn
Dec 31, 2023 107.24 Mn